Since our last edition of this report in 2007, the oral drug delivery market is the largest segment of the drug delivery market, and there’s no sign that it is slowing down. With pharmaceutical companies increasingly turning to drug delivery to extend the revenue-earning lifetime of their biggest products, and seeking to tap into the growing elderly population that requires products with a level of ease-of-use and cost benefit, it’s no surprise that the oral drug delivery market is a $35 billion industry and expected to grow as much as ten percent per year.
Kalorama’s Drug Delivery Markets: Oral Delivery provides the definitive break down of the market for oral delivery drug markets. The report covers both the major technologies in oral delivery (controlled-release, delayed release, pulsatile-release, taste-masked and microemulsion formulations) and the products that use these delivery technologies.
In the reporting of market size and growth through 2013, Kalorama’s unique analysis breaks out separates the value of the technology portion of the market from the active ingriedient portion of the market, allowing for a deeper understanding of the value of the market attributable to the delivery technologies themselves.
This focused report provides information on the revenues for relevant companies and provides information critical to assessing the opportunities available in this market, including:
Legacy Companies in Oral Delivery as well as Recent Entrants
Current World Wide Revenue Across Product Categories and Future Forecasts
Revenues by Combonent and by Component ( Pharmaceutical vs. Technology portion of Revenue) Type of Delivery (Timed Release vs. Other)
Challenges Faced by Oral-Delivery Technology Companies
Success Stories and Pitfalls
The Trends That are Expected to Lead to Global Growth
Kalorama’s trusted information-gathering process provides most accurate study of the oral delivery drug market available today. Information and analysis presented in this report is based on extensive interviews with senior management of top companies in the industry. While major research literature and government information is culled, information is corroborated and key market insights originate from interviews with industry leaders.
Product managers, marketing managers, business development executives, advertising agency or investment firm executives, and information and research center librarians are among the individuals who will find this report on the oral delivery drug market essential.
New York, July 14, 2009 — The worldwide market for oral drugs using drug delivery technologies has experienced tremendous growth over the last few years according to Drug Delivery Markets: Oral Delivery, a new report from Kalorama Information, a leading publisher in the life sciences research market, a trajectory that is projected to gain momentum through 2013 as other pharmaceutical product areas are challenged.
In 2008, the oral drug delivery market reached revenues at the manufacturer’s level of $43 billion for both major technologies in oral delivery and the products that use these delivery technologies. Kalorama forecasts the market will reach $71 billion by 2013, with a compound annual growth rate (CAGR) of almost 11% for the five-year period beginning in 2009.
Over the next few years, Kalorama projects consolidation will increasingly impact the market as funding from big companies leads to better products and more research and development. Large pharmaceutical companies are expected to continue acquiring drug delivery companies to expand their presence, deepen product lines, and create potential extensions for existing products; while larger drug delivery companies will continue to acquire smaller start-up companies to broaden their drug delivery platforms.
“Those products with enhanced delivery technologies have a better chance of meeting economic and patent challenges near-term,” says Bruce Carlson, publisher of Kalorama Information. “That’s why we will see drug delivery companies become more involved earlier in the research and development process. Higher-quality products with exceptional drug delivery methods will encourage patient compliance and innovative discoveries.”
Additional market drivers include growth in the elderly population, patent issues among large pharmaceutical companies, differentiation of existing and future products by drug delivery mechanism, population growth, and new developments in drug delivery that are both fueling growth in the pharmaceutical market and providing opportunities to extend product lifecycles.
Drug Delivery Markets: Oral Delivery provides the definitive breakdown of the global oral drug delivery market. The report covers both the major technologies in oral delivery (controlled-release, delayed release, pulsatile-release, taste-masked and microemulsion formulations) and the products that use these delivery technologies. Included are market size and growth through 2013, in addition to information critical to assessing the opportunities available in the market.
About Kalorama Information
Kalorama Information supplies the latest in independent market research in the life sciences, as well as a full range of custom research services.